Baseline (n = 28)* | Baseline (n = 19) | End-of-Treatment (3 Months) (n = 19) | Second Assessment (6 Months) (n = 16) | Third Assessment (9 Months) (n = 15) | |
---|---|---|---|---|---|
EDE | 3.5 (1.0) | 3.5 (1.1) | 2.5 (1.0) | - | - |
DEPS-R | 41.3 (12.8) | 42.7 (13.9) | 25.3 (10.8) | 26.3 (11.8) | 28.3 (14.9) |
DSMQ | 4.7 (1.6) | 4.7 (1.5) | 6.3 (1.5) | 6.1 (1.8) | 6.4 (1.0) |
HbA1c (%) | 9.9 (2.8) | 9.8 (2.7) | 8.9 (2.4) | 8.5 (1.9) | 9.3 (2.4) |
DDS | 3.8 (.7) | 3.8 (.6) | 2.8 (.7) | 2.7 (.7) | 2.7 (.93) |
PROMIS-D | 60.2 (6.7) | 61.0 (6.9) | 57.0 (7.7) | 56.5 (8.2) | 55.8 (11.3) |
PROMIS-A | 61.2 (7.3) | 60.84 (7.7) | 58.5 (10.2) | 56.1 (8.5) | 58.5 (10.4) |
AADQ | 49.9 (7.7) | 49.2 (6.9) | 56.1 (4.9) | 56.1 (6.1) | 56.2 (7.5) |